Hyperhomocysteinaemia and chronic venous ulcers

Stefano de Franciscis1, Giovambattista De Sarro, Paola Longo

  • 1Department of Medical and Surgical Science, School of Medicine, University Magna Graecia of Catanzaro, Catanzaro, Italy; Interuniversity Center of Phlebolymphology, International Research and Educational Program in Clinical and Experimental Biotechnology, University Magna Graecia of Catanzaro, Catanzaro, Italy.

International Wound Journal
|February 20, 2013
PubMed

Insights

Hyperhomocysteinemia (HHcy) is common in chronic venous ulcers (CVU). Folic acid therapy improved healing rates in patients with HHcy, suggesting a link between homocysteine levels and venous ulcer recovery.

Area of Science:

  • Vascular Medicine
  • Dermatology
  • Wound Healing Research

Background:

  • Chronic venous ulceration (CVU) is a significant complication of chronic venous disease affecting lower extremities.
  • Previous research suggests a potential link between thrombophilic factors, like hyperhomocysteinemia (HHcy), and the development of chronic venous ulcers.

Purpose of the Study:

  • To determine the prevalence of HHcy in patients diagnosed with venous leg ulcers.
  • To investigate the impact of folic acid therapy on the healing of chronic venous ulcers in patients with HHcy.

Main Methods:

  • Eighty-seven patients with venous leg ulcers were enrolled.
  • All patients received standard care (compression therapy ± surgery).
  • Patients with HHcy received folic acid (1.2 mg/day for 12 months), while controls did not. Wound healing was assessed using computerized planimetry.

Main Results:

  • The prevalence of HHcy among patients with chronic venous ulcers was found to be 62.06%.
  • A statistically significant higher healing rate (P < 0.05) was observed in the folic acid treatment group (78.75%) compared to the control group (63.33%).

Conclusions:

  • A significant association exists between hyperhomocysteinemia and chronic venous ulceration.
  • Folic acid therapy appears to accelerate wound healing in patients with HHcy and CVU, though underlying mechanisms require further investigation.

Related Concept Videos

Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease I: Introduction01:25

Peptic Ulcer Disease I: Introduction

Peptic ulcer disease (PUD) involves breaks in the gastrointestinal tract's mucosal lining, primarily in the stomach and duodenum, with less frequent occurrences in the lower esophagus or near the pylorus.Ulcers can be acute or chronic. Acute ulcers are short-lived with minimal inflammation and heal quickly after the irritant is removed. Chronic ulcers persist, may recur, and often cause scarring due to ongoing tissue damage. Superficial erosions affect only the mucosal layer and are called...